Mahajan, R. (2009). Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes. Medknow Publications.
シカゴスタイル引用形Mahajan, Rajiv. Bromocriptine Mesylate: FDA-approved Novel Treatment for Type-2 Diabetes. Medknow Publications, 2009.
MLA引用形式Mahajan, Rajiv. Bromocriptine Mesylate: FDA-approved Novel Treatment for Type-2 Diabetes. Medknow Publications, 2009.
警告: この引用は必ずしも正確ではありません.